nach oben

American Journal of Clinical Dermatology

07.03.2024 | Therapy in Practice

Management of Acne in Pregnancy

verfasst von: Akash Rau, Jonette Keri, Jenny E. Murase

Erschienen in: American Journal of Clinical Dermatology

Einloggen, um Zugang zu erhalten

Abstract

Acne is one of the most common dermatological conditions to affect women of childbearing age, so it is important to consider the safety of long-term acne treatments on women who could become pregnant. In this review article, we clarify what management options are available to treat acne during pregnancy. Topical treatments, typically first-line for acne, such as azelaic acid, clindamycin, erythromycin, metronidazole, benzoyl peroxide, salicylic acid, dapsone, and retinoids, were reviewed. Systemic treatments, such as zinc supplements, cephalexin, cefadroxil, amoxicillin, azithromycin, erythromycin, and corticosteroids, typically second-line for acne, were also reviewed. Alternative treatments such as light therapy and cosmetic procedures were also evaluated. Due to recommendation of sunscreen utilization during acne treatments, sunscreen usage during pregnancy was also assessed. Management of acne during unplanned pregnancy was discussed in further detail regarding safety and adverse effects. Through summarized tables and examples of studies demonstrating safety and efficacy of treatments, the following is a resource for providers and patients to utilize for management of acne during pregnancy.

Landis MN. Optimizing isotretinoin treatment of acne: update on current recommendations for monitoring, dosing, safety, adverse effects, compliance, and outcomes. Am J Clin Dermatol. 2020;21(3):411–9. https://doi.org/10.1007/s40257-020-00508-0.CrossRefPubMed

Nussbaum R, Benedetto AV. Cosmetic aspects of pregnancy. Clin Dermatol. 2006;24(2):133–41. https://doi.org/10.1016/j.clindermatol.2005.10.007.CrossRefPubMed

Bechstein SK, Ochsendorf F. Akne und Rosazea in der Schwangerschaft [Acne and rosacea in pregnancy]. Der Hautarzt Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2017;68(2):111–9. https://doi.org/10.1007/s00105-016-3918-8.CrossRefPubMed

Kutlu Ö, Karadağ AS, Ünal E, Kelekçi KH, Yalçınkayaİyidal A, TopaloğluDemir F, Aksoy B, Çölgeçen E, Tosun M, Emre S, Tatlıparmak A, Demirseren DD, Kaya Özden H, Öztürk M, Özlü E, Chen W. Acne in pregnancy: a prospective multicenter, cross-sectional study of 295 patients in Turkey. Int J Dermatol. 2020;59(9):1098–105. https://doi.org/10.1111/ijd.14999.CrossRefPubMed

Ly S, Kamal K, Manjaly P, Barbieri JS, Mostaghimi A. Treatment of acne vulgaris during pregnancy and lactation: a narrative review. Dermatol Ther. 2023;13(1):115–30. https://doi.org/10.1007/s13555-022-00854-3.CrossRef

Blattner CM, Danesh M, Safaee M, Murase JE. Understanding the new FDA pregnancy and lactation labeling rules. Int J Women’s Dermatol. 2016;2(1):5–7. https://doi.org/10.1016/j.ijwd.2015.12.005.CrossRef

Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther. 1998;20(5):945–59. https://doi.org/10.1016/s0149-2918(98)80076-3.CrossRefPubMed

Chien AL, Qi J, Rainer B, Sachs DL, Helfrich YR. Treatment of acne in pregnancy. J Am Board of Family Med JABFM. 2016;29(2):254–62. https://doi.org/10.3122/jabfm.2016.02.150165.CrossRef

Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Am Acad Dermatol. 2014;70(3):401.e1-415. https://doi.org/10.1016/j.jaad.2013.09.010.CrossRefPubMed

10.

Trivedi NA. A meta-analysis of low-dose aspirin for prevention of preeclampsia. J Postgrad Med. 2011;57(2):91–5. https://doi.org/10.4103/0022-3859.81858.CrossRefPubMed

11.

Tuffanelli DL. Successful pregnancy in a patient with dermatitis herpetiformis treated with low-dose dapsone. Arch Dermatol. 1982;118(11):876.CrossRefPubMed

12.

Kraeling ME, Bronaugh RL. In vitro percutaneous absorption of alpha hydroxy acids in human skin. J Soc Cosmet Chem. 1997;48:187–97.

13.

Munley SM, Kennedy GL, Hurtt ME. Developmental toxicity study of glycolic acid in rats. Drug Chem Toxicol. 1999;22(4):569–82. https://doi.org/10.3109/01480549908993168.CrossRefPubMed

14.

Peterson H, Kircik L, Armstrong AW. Individual article: clascoterone cream 1%: mechanism of action, efficacy, and safety of a novel, first-in-class topical antiandrogen therapy for acne. J Drugs Dermatol. 2023;22(6):SF350992s7-SF350992s14.PubMed

15.

Panchaud A, Csajka C, Merlob P, Schaefer C, Berlin M, De Santis M, Vial T, Ieri A, Malm H, Eleftheriou G, Stahl B, Rousso P, Winterfeld U, Rothuizen LE, Buclin T. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. J Clin Pharmacol. 2012;52(12):1844–51. https://doi.org/10.1177/0091270011429566.CrossRefPubMed

16.

Shapiro L, Pastuszak A, Curto G, Koren G. Safety of first-trimester exposure to topical tretinoin: prospective cohort study. Lancet (London, England). 1997;350(9085):1143–4. https://doi.org/10.1016/S0140-6736(05)63790-7.CrossRefPubMed

17.

Weiss J, Mallavalli S, Meckfessel M, Griffin S, Wagner N. Safe use of adapalene 0.1% gel in a non-prescription environment. J Drugs iDermatol JDD. 2021;20(12):1330–5. https://doi.org/10.36849/jdd.6527.CrossRefPubMed

18.

Highlights of Prescribing DIFFERIN (adapelene) Gel, 0.3%. (n.d.). Retrieved November 16, 2023, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021753s002lbl.pdf. Accessed on 10 Dec 2023.

19.

Adapalene Cream, 0.1%. (n.d.). Dailymed.nlm.nih.gov. Retrieved November 16, 2023, from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=94cf9af1-afab-4064-a2ca-619b54218262&type=display. Accessed on 10 Dec 2023.

20.

Han G, Wu JJ, Del Rosso JQ. Use of topical tazarotene for the treatment of acne vulgaris in pregnancy: a literature review. J Clin Aesth Dermatol. 2020;13(9):E59–65.

21.

Lin KJ, Mitchell AA, Yau WP, Louik C, Hernández-Díaz S. Maternal exposure to amoxicillin and the risk of oral clefts. Epidemiology. 2012;23(5):699–705. https://doi.org/10.1097/EDE.0b013e318258cb05.CrossRefPubMedPubMedCentral

22.

Hale EK, Pomeranz MK. Dermatologic agents during pregnancy and lactation: an update and clinical review. Int J Dermatol. 2002;41(4):197–203. https://doi.org/10.1046/j.1365-4362.2002.01464.x.CrossRefPubMed

23.

Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautam S, Ray WA. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med. 2002;156(7):647–50. https://doi.org/10.1001/archpedi.156.7.647.CrossRefPubMed

24.

Awan SZ, Lu J. Management of severe acne during pregnancy: A case report and review of the literature. Int J women’s Dermatol. 2017;3(3):145–50. https://doi.org/10.1016/j.ijwd.2017.06.001.CrossRef

25.

Forestiero V, Sconfienza E, Mulatero P, Monticone S. Primary aldosteronism in pregnancy. Rev Endocr Metab Disord. 2023;24(1):39–48. https://doi.org/10.1007/s11154-022-09729-6.CrossRefPubMed

26.

Dréno B, Blouin E. Acné de la femme enceinte et sels de zinc: revue de la littérature [Acne, pregnant women and zinc salts: a literature review]. Ann Dermatol Venereol. 2008;135(1):27–33. https://doi.org/10.1016/j.annder.2007.07.001.CrossRefPubMed

27.

Grzeszczak K, Kwiatkowski S, Kosik-Bogacka D. The role of Fe, Zn, and Cu in PRegnancy. Biomolecules. 2020;10(8):1176. https://doi.org/10.3390/biom10081176.CrossRefPubMedPubMedCentral

28.

Yee BE, Richards P, Sui JY, Marsch AF. Serum zinc levels and efficacy of zinc treatment in acne vulgaris: A systematic review and meta-analysis. Dermatol Ther. 2020;33(6): e14252. https://doi.org/10.1111/dth.14252.CrossRefPubMed

29.

Miller RK, Hendrickx AG, Mills JL, Hummler H, Wiegand UW. Periconceptional vitamin A use: how much is teratogenic? Reprod Toxicol (Elmsford, NY). 1998;12(1):75–88. https://doi.org/10.1016/s0890-6238(97)00102-0.CrossRef

30.

Zamil DH, Burns EK, Perez-Sanchez A, Parke MA, Katta R. Risk of birth defects from vitamin A “Acne Supplements” sold online. Dermatol Pract Concept. 2021;11(3): e2021075. https://doi.org/10.5826/dpc.1103a75.CrossRefPubMedPubMedCentral

31.

Trivedi MK, Kroumpouzos G, Murase JE. A review of the safety of cosmetic procedures during pregnancy and lactation. Int J Women’s Dermatol. 2017;3(1):6–10. https://doi.org/10.1016/j.ijwd.2017.01.005.CrossRef

32.

Li H, Zheng J, Wang H, Huang G, Huang Q, Feng N, Xiao J. Maternal cosmetics use during pregnancy and risks of adverse outcomes: a prospective cohort study. Sci Rep. 2019;9(1):8030. https://doi.org/10.1038/s41598-019-44546-z.ADSCrossRefPubMedPubMedCentral

33.

Piquero-Casals J, Morgado-Carrasco D, Rozas-Muñoz E, Mir-Bonafé JF, Trullàs C, Jourdan E, Piquero-Martin J, Zouboulis CC, Krutmann J. Sun exposure, a relevant exposome factor in acne patients and how photoprotection can improve outcomes. J Cosmet Dermatol. 2023;22(6):1919–28. https://doi.org/10.1111/jocd.15726. (Epub 2023 Mar 22 PMID: 36946555).CrossRefPubMed

34.

Gonzalez H, Farbrot A, Larkö O, Wennberg AM. Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol. 2006;154(2):337–40. https://doi.org/10.1111/j.1365-2133.2005.07007.x.CrossRefPubMed

35.

Putra IB, Jusuf NK, Dewi NK. Skin changes and safety profile of topical products during pregnancy. J Clin Aesth Dermatol. 2022;15(2):49–57.

36.

Viola KV, Grant-Kels JM. Oxybenzone and pregnancy: time for more research and patient education. J Am Acad Dermatol. 2023;89(2):435–6. https://doi.org/10.1016/j.jaad.2021.11.049.CrossRefPubMed

37.

Ryu HJ, Seo MY, Jung SK, Maeng EH, Lee SY, Jang DH, Lee TJ, Jo KY, Kim YR, Cho KB, Kim MK, Lee BJ, Son SW. Zinc oxide nanoparticles: a 90-day repeated-dose dermal toxicity study in rats. Int J Nanomed. 2014;9 Suppl 2(Suppl 2):137–44. https://doi.org/10.2147/IJN.S57930.CrossRef

38.

Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet (London, England). 1993;341(8854):1181–2. https://doi.org/10.1016/0140-6736(93)91004-6.CrossRefPubMed

39.

Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A. 2005;136(2):117–21. https://doi.org/10.1002/ajmg.a.30744.CrossRefPubMed

40.

Kaplan YC, Ozsarfati J, Etwel F, Nickel C, Nulman I, Koren G. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis. Br J Dermatol. 2015;173(5):1132–41. https://doi.org/10.1111/bjd.14053.CrossRefPubMed

41.

Horne HW Jr, Kundsin RB. The role of mycoplasma among 81 consecutive pregnancies: a prospective study. Int J Fertil. 1980;25(4):315–7.PubMed

42.

Baldwin HE. Treating acne during pregnancy and lactation. Cutis. 2015;96(1):11–2.PubMed

Titel: Management of Acne in Pregnancy
verfasst von: Akash Rau
Jonette Keri
Jenny E. Murase
Publikationsdatum: 07.03.2024
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.1007/s40257-024-00851-6

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen